GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers. - Lesueur F; Mebirouk N; Jiao Y; Barjhoux L; Belotti M; Laurent M; Léone M; Houdayer C; Bressac-de Paillerets B; Vaur D; Sobol H; Noguès C; et al. (Frontiers in oncology, 2018)